9
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Bone morphogenetic protein 6–mediated crosstalk between endothelial cells and hepatocytes recapitulates the iron-sensing pathway in vitro

      research-article
      , , , , ,
      The Journal of Biological Chemistry
      American Society for Biochemistry and Molecular Biology
      endothelial cells, BMP6–SMAD pathway, hepatocytes, hepcidin, iron metabolism, ALK, ALK receptor tyrosine kinase, BMP6, bone morphogenetic protein 6, BMPER, BMP-binding endothelial regulator, CM, conditioned medium, EC, endothelial cell, ECGM, endothelial cell growth medium, FAC, ferric ammonium citrate, FCS, fetal calf serum, hemin, ferric chloride heme, HJV, hemojuvelin, HUVEC, human umbilical vein endothelial cell, Id1, inhibitor of DNA binding 1, LDN, LDN193189 hydrochloride, LSEC, liver sinusoidal endothelial cell, pSMAD1/5/8, phosphorylated small mothers against decapentaplegic 1,5,8, qRT-PCR, real-time quantitative PCR, SFG, sodium ferric gluconate, SMAD1, small mothers against decapentaplegic homolog 1, STAT3, signal transducer and activator of transcription 3

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Liver sinusoidal endothelial cell–derived bone morphogenetic protein 6 (BMP6) and the BMP6–small mothers against decapentaplegic homolog (SMAD) signaling pathway are essential for the expression of hepcidin, the secretion of which is considered the systemic master switch of iron homeostasis. However, there are continued controversies related to the strong and direct suppressive effect of iron on hepatocellular hepcidin in vitro in contrast to in vivo conditions. Here, we directly studied the crosstalk between endothelial cells (ECs) and hepatocytes using in vitro coculture models that mimic hepcidin signaling in vivo. Huh7 cells were directly cocultured with ECs, and EC conditioned media (CM) were also used to culture Huh7 cells and primary mouse hepatocytes. To explore the reactions of ECs to surrounding iron, they were grown in the presence of ferric ammonium citrate and heme, two iron-containing molecules. We found that both direct coculture with ECs and EC-CM significantly increased hepcidin expression in Huh7 cells. The upstream SMAD pathway, including phosphorylated SMAD1/5/8, SMAD1, and inhibitor of DNA binding 1, was induced by EC-CM, promoting hepcidin expression. Efficient blockage of this EC-mediated hepcidin upregulation by an inhibitor of the BMP6 receptor ALK receptor tyrosine kinase 2/3 or BMP6 siRNA identified BMP6 as a major hepcidin regulator in this coculture system, which highly fits the model of hepcidin regulation by iron in vivo. In addition, EC-derived BMP6 and hepcidin were highly sensitive to levels of not only ferric iron but also heme as low as 500 nM. We here establish a hepatocyte–endothelial coculture system to fully recapitulate iron regulation by hepcidin using EC-derived BMP6.

          Related collections

          Most cited references52

          • Record: found
          • Abstract: found
          • Article: not found

          Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization.

          E Németh (2004)
          Hepcidin is a peptide hormone secreted by the liver in response to iron loading and inflammation. Decreased hepcidin leads to tissue iron overload, whereas hepcidin overproduction leads to hypoferremia and the anemia of inflammation. Ferroportin is an iron exporter present on the surface of absorptive enterocytes, macrophages, hepatocytes, and placental cells. Here we report that hepcidin bound to ferroportin in tissue culture cells. After binding, ferroportin was internalized and degraded, leading to decreased export of cellular iron. The posttranslational regulation of ferroportin by hepcidin may thus complete a homeostatic loop: Iron regulates the secretion of hepcidin, which in turn controls the concentration of ferroportin on the cell surface.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein.

            Hepcidin is a liver-made peptide proposed to be a central regulator of intestinal iron absorption and iron recycling by macrophages. In animal models, hepcidin is induced by inflammation and iron loading, but its regulation in humans has not been studied. We report that urinary excretion of hepcidin was greatly increased in patients with iron overload, infections, or inflammatory diseases. Hepcidin excretion correlated well with serum ferritin levels, which are regulated by similar pathologic stimuli. In vitro iron loading of primary human hepatocytes, however, unexpectedly down-regulated hepcidin mRNA, suggesting that in vivo regulation of hepcidin expression by iron stores involves complex indirect effects. Hepcidin mRNA was dramatically induced by interleukin-6 (IL-6) in vitro, but not by IL-1 or tumor necrosis factor alpha (TNF-alpha), demonstrating that human hepcidin is a type II acute-phase reactant. The linkage of hepcidin induction to inflammation in humans supports its proposed role as a key mediator of anemia of inflammation.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              BMP6 is a key endogenous regulator of hepcidin expression and iron metabolism.

              Juvenile hemochromatosis is an iron-overload disorder caused by mutations in the genes encoding the major iron regulatory hormone hepcidin (HAMP) and hemojuvelin (HFE2). We have previously shown that hemojuvelin is a co-receptor for bone morphogenetic proteins (BMPs) and that BMP signals regulate hepcidin expression and iron metabolism. However, the endogenous BMP regulator(s) of hepcidin in vivo is unknown. Here we show that compared with soluble hemojuvelin (HJV.Fc), the homologous DRAGON.Fc is a more potent inhibitor of BMP2 or BMP4 but a less potent inhibitor of BMP6 in vitro. In vivo, HJV.Fc or a neutralizing antibody to BMP6 inhibits hepcidin expression and increases serum iron, whereas DRAGON.Fc has no effect. Notably, Bmp6-null mice have a phenotype resembling hereditary hemochromatosis, with reduced hepcidin expression and tissue iron overload. Finally, we demonstrate a physical interaction between HJV.Fc and BMP6, and we show that BMP6 increases hepcidin expression and reduces serum iron in mice. These data support a key role for BMP6 as a ligand for hemojuvelin and an endogenous regulator of hepcidin expression and iron metabolism in vivo.
                Bookmark

                Author and article information

                Contributors
                Journal
                J Biol Chem
                J Biol Chem
                The Journal of Biological Chemistry
                American Society for Biochemistry and Molecular Biology
                0021-9258
                1083-351X
                02 November 2021
                December 2021
                02 November 2021
                : 297
                : 6
                : 101378
                Affiliations
                [1]Center for Alcohol Research and Salem Medical Center, University of Heidelberg, Heidelberg, Germany
                Author notes
                []For correspondence: Sebastian Mueller sebastian.mueller@ 123456urz.uni-heidelberg.de
                Article
                S0021-9258(21)01184-4 101378
                10.1016/j.jbc.2021.101378
                8637636
                34740612
                68c5ec73-e71f-4a64-95a4-d137b9006f79
                © 2021 The Authors

                This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).

                History
                : 18 August 2021
                : 26 October 2021
                Categories
                Research Article

                Biochemistry
                endothelial cells,bmp6–smad pathway,hepatocytes,hepcidin,iron metabolism,alk, alk receptor tyrosine kinase,bmp6, bone morphogenetic protein 6,bmper, bmp-binding endothelial regulator,cm, conditioned medium,ec, endothelial cell,ecgm, endothelial cell growth medium,fac, ferric ammonium citrate,fcs, fetal calf serum,hemin, ferric chloride heme,hjv, hemojuvelin,huvec, human umbilical vein endothelial cell,id1, inhibitor of dna binding 1,ldn, ldn193189 hydrochloride,lsec, liver sinusoidal endothelial cell,psmad1/5/8, phosphorylated small mothers against decapentaplegic 1,5,8,qrt-pcr, real-time quantitative pcr,sfg, sodium ferric gluconate,smad1, small mothers against decapentaplegic homolog 1,stat3, signal transducer and activator of transcription 3

                Comments

                Comment on this article